USD 0.0
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | -2.16 Million | -1.61 Million | -22.78 Thousand | -9838.00 | -27.31 Thousand |
Net Income | - | -5.52 Million | -2.23 Million | -33.68 Thousand | -13.89 Thousand | -27.58 Thousand |
Depreciation & Amortization | - | 322.85 Thousand | 272.77 Thousand | 215.00 | 270.00 | 271.00 |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | 1.05 Million | - | - | - | - |
Change in working capital | - | 659.31 Thousand | 348.03 Thousand | 10.67 Thousand | 3791.00 | -178.00 |
Other non-cash items | - | 1.32 Million | 594.96 Thousand | 430.00 | 540.00 | 178.00 |
Investing Cash Flow | - | -269.25 Thousand | -2.18 Million | -684.02 | - | - |
Investments in PPE | - | -269.25 Thousand | -2.18 Million | -60.27 | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | -1801.00 | -623.75 | - | - |
Financing Cash Flow | - | 2.4 Million | 3.83 Million | 21.73 Thousand | 7700.00 | 26.63 Thousand |
Debt repayment | - | -684.67 Thousand | -4.97 Million | -21.73 Thousand | -7700.00 | -500.00 |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | -410 Thousand | -40.15 Thousand | - | - | - |
Common Stock Issuance | - | 470.5 Thousand | - | - | - | 27.13 Thousand |
Other Financing Activities | - | 3.03 Million | 8.84 Million | 43.47 Thousand | 15.4 Thousand | -500.00 |
Accounts receivables | - | -168.6 Thousand | -38.34 Thousand | 13.00 | - | - |
Accounts payables | - | 427.5 Thousand | 152.13 Thousand | -791.00 | 791.00 | - |
Inventory | - | -24 Thousand | -16 Million | -13.00 | -1390.50 | - |
Other working capital | - | 424.41 Thousand | 16.23 Million | 11.46 Thousand | 3000.00 | -178.00 |
Cash at beginning of period | 1894.00 | 28.76 Thousand | -1.00 | 1053.00 | 3191.00 | 3869.00 |
Cash at end of period | 1894.00 | 1894.00 | 28.76 Thousand | 9.56 | 1053.00 | 3191.00 |
Capital Expenditure | - | -269.25 Thousand | -2.18 Million | -60.27 | - | - |
Effect of forex changes on cash | - | 1.00 | - | 684.02 | - | - |
Net cash flow / Change in cash | - | -26.86 Thousand | 28.76 Thousand | -1043.44 | -2138.00 | -678.00 |
Free Cash Flow | - | -2.43 Million | -3.8 Million | -22.84 Thousand | -9838.00 | -27.31 Thousand |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | - | - | - | - | -634.61 Thousand |
Depreciation & Amortization | - | - | - | - | - | 95.44 Thousand |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | 489.93 Thousand |
Other non-cash items | - | - | - | - | - | -3656.00 |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | 54 Thousand |
Debt repayment | - | - | - | - | - | -54 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | 108 Thousand |
Accounts receivables | - | - | - | - | - | -29.75 Thousand |
Accounts payables | - | - | - | - | - | 255.59 Thousand |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | 264.08 Thousand |
Cash at beginning of period | - | - | - | 1894.00 | - | -1107.00 |
Cash at end of period | - | - | - | 1894.00 | - | - |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | - | 1107.00 |
Free Cash Flow | - | - | - | - | - | -52.89 Thousand |
FUNO11
DEL
ATA
ASB-PF
ACRI-B
CMRS